KBH vs TSLA

KB Home exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9, indicating robust operational efficiency and financial stability. While the stock is fundamentally undervalued from a defensive standpoint (Graham Number: $84.69, P/B: 0.88), it is currently battling a severe cyclical downturn characterized by a 65% drop in YoY earnings and a 22.6% decline in revenue. The divergence between the high Graham Number and the low growth-based intrinsic value ($36.26) highlights a conflict between asset value and current earnings momentum. Consequently, the stock is a value play with significant headwinds in growth and technical sentiment.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.